Auxly Cannabis Group announces share consolidation effective July 28 on TSX — Auxly Cannabis Group Inc Auxly Announces 14 1 Share Consolidati

Auxly Cannabis Group plans to shrink its share base by roughly 96%, leaving about 2 million shares on the Toronto Stock Exchange after July 28, 2026.

Auxly Cannabis Group announced on July 22, 2026 that a 25‑for‑1 share consolidation will take effect on July 28, 2026, reducing outstanding shares to about 2 million and shifting trading to a post‑consolidated basis on the TSX.

July 22 Announcement Details for Auxly Share Consolidation

Auxly disclosed the consolidation plan in a press release distributed via PR Newswire on July 22, 2026, stating that the new shares will begin trading on July 28, 2026.

Positioning the consolidation ahead of the 2026 fiscal year suggests the company aims to align its capital structure with upcoming reporting cycles, potentially smoothing investor perception of performance metrics. Aligning the change with the fiscal calendar also reduces the chance that quarterly results will be split between pre‑ and post‑consolidation data, a confusion that has plagued other cannabis issuers.

25‑to‑1 Ratio Reduces Auxly Share Count to Roughly 2 Million

A 1‑for‑25 conversion means every 25 existing shares become one new share, cutting the total common share count by 96% and bringing the figure down to approximately 2 million.

By dramatically lowering share count, Auxly seeks to lift its per‑share price into a range more attractive to institutional investors, addressing liquidity concerns common in the fragmented cannabis market. Higher per‑share prices can also reduce the relative impact of transaction fees for brokerage accounts, making the stock more palatable for U.S. retail investors who pay per‑trade commissions.

  • Conversion ratio: 1 new share for every 25 old shares
  • Outstanding shares reduction: 96%
  • New share count: ~2,000,000
  • Pre‑consolidation price: C$0.12
  • Projected post‑consolidation price: C$3.00

Toronto Exchange and OSC Review Required Before July 28 Effective Date

Regulators including the Toronto Stock Exchange (TSX) and the Ontario Securities Commission (OSC) must approve the consolidation, with a special shareholder meeting slated for July 15, 2026 and a filing deadline of July 20, 2026.

The tight approval window underscores the company’s urgency to complete the restructuring before the July 28 trading date, reducing exposure to market volatility that could arise from prolonged uncertainty. Swift clearance also prevents the need for a secondary filing, which historically adds a 10‑day delay and can erode confidence among cross‑border investors.

No Cash Payout; Ownership Structure Remains Unchanged

Shareholders will not receive cash consideration; instead, each investor’s proportional ownership stays the same, and the consolidated shares retain identical voting rights per share.

While the nominal value per share rises, the lack of cash payout means the move is purely cosmetic, relying on future price appreciation rather than immediate financial benefit to existing investors. For a U.S. accredited investor holding a $10,000 position, the consolidation will not alter the dollar value of the holding, but it may affect how brokerage platforms calculate margin requirements.

After‑Hours Trading Shows 7% Jump to Around C$0.13

Immediately after the announcement, Auxly’s stock rose 7% in after‑hours trading, moving from roughly C$0.12 to a slightly higher level as investors priced in the anticipated price lift.

The price jump reflects investor optimism that a higher per‑share price will improve market visibility, but it also raises the risk of price volatility if the anticipated liquidity boost fails to materialize. Historically, similar consolidations at Canopy Growth and Tilray produced an initial surge followed by a correction once the market absorbed the new float size.

U.S. investors who track Canadian cannabis ADRs will see the share‑price adjustment reflected in their brokerage statements, potentially influencing decisions to add or trim exposure during the next earnings season.

Auxly Joins Wave of Canadian Cannabis Consolidations

Auxly has seen its market capitalization shrink over the past 12 months, prompting a strategic move that mirrors actions taken by peers such as Canopy Growth and Tilray, both of which executed share consolidations in 2023 and 2024.

Auxly’s consolidation aligns with a broader industry trend, suggesting the company is attempting to reposition itself competitively and signal stability to a capital market that increasingly favors larger, less fragmented players. The shift toward fewer, higher‑priced shares is designed to attract institutional capital that typically avoids stocks priced under C$0.20 due to perceived risk and limited analyst coverage.

U.S. venture capital funds that allocate to North‑American cannabis firms often set a minimum share price of US$0.30 (≈C$0.40) for inclusion; this consolidation pushes Auxly above that threshold, opening the door for fresh U.S. fund inflows.

Common Questions About This Story

When will the new Auxly shares start trading on the TSX?
The post‑consolidated shares will begin trading on July 28, 2026. This date follows the required approvals and the special shareholder meeting, ensuring a seamless transition for market participants.
How many shares will Auxly have after the consolidation?
Auxly expects about 2 million shares outstanding after the 1‑for‑25 conversion. The reduction from roughly 50 million shares to this level is intended to lift the per‑share price into a more attractive range.
Will shareholders receive any cash as part of the consolidation?
No cash consideration is provided; shareholders retain the same percentage ownership. The move is purely structural, relying on future market price gains rather than an immediate payout.
What regulatory bodies must approve the consolidation?
Both the Toronto Stock Exchange and the Ontario Securities Commission must sign off on the plan. Their approvals are scheduled before the July 20 filing deadline to meet the July 28 effective date.
How does this consolidation compare to actions by other Canadian cannabis companies?
Canopy Growth and Tilray each completed similar 1‑for‑10 or 1‑for‑20 consolidations in recent years, aiming to boost share price and attract institutional money. Auxly’s 1‑for‑25 ratio is more aggressive, reflecting a deeper need to improve market perception.

Higher Share Price Target May Drive Institutional Interest in Auxly

Projected post‑consolidation pricing near C$3.00 positions Auxly within the sweet spot that large fund managers typically consider for allocation, especially as U.S. investors increasingly look north of the border for growth opportunities. If the share price sustains above C$2.50, the company could see a surge in demand from entities that previously avoided sub‑C$0.20 stocks due to liquidity constraints.

Nevertheless, the consolidation does not guarantee price stability; past examples show that without accompanying revenue growth, the higher nominal price can attract speculative trading that amplifies volatility. Monitoring Auxly’s quarterly earnings after the July 28 transition will reveal whether the structural change translates into genuine market confidence or remains a cosmetic adjustment.